Origin Therapeutics Holdings, Inc. (TSE:SPLY) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Safe Supply is set to acquire Drug Lab 118 Ltd.’s subsidiary, enhancing its medical testing portfolio with proprietary harm reduction test strips for the North American market. The deal involves the issuance of 10 million Safe Supply shares and the addition of a Drug Lab Parent nominee to Safe Supply’s board. This strategic move aims to capitalize on the growing market for narcotic testing and harm reduction solutions.
For further insights into TSE:SPLY stock, check out TipRanks’ Stock Analysis page.
